Roivant Sciences Ltd. Quarterly Income Tax Expense (Benefit) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Roivant Sciences Ltd. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q2 2024.
  • Roivant Sciences Ltd. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $12.7M, a 622% increase year-over-year.
  • Roivant Sciences Ltd. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $33.1M, a 1026% increase year-over-year.
  • Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2023 was $22.2M, a 328% increase from 2022.
  • Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2022 was $5.19M, a 1307% increase from 2021.
  • Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2021 was $369K, a 78.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $33.1M $12.7M +$10.9M +622% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $22.2M -$8.96M -$5.16M -136% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-30
Q4 2023 $27.4M $25.7M +$22.9M +811% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $4.54M $3.76M +$1.59M +73.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.94M $1.75M -$2.25M -56.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $5.19M -$3.79M -$3.63M -2227% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-30
Q4 2022 $8.82M $2.82M +$2.78M +7318% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $6.04M $2.17M +$1.76M +440% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $4.28M $4M +$3.91M +4200% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $369K -$163K -$141K -641% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 $510K $38K +$262K Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $248K $401K -$310K -43.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $558K $93K -$1.13M -92.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.69M -$22K Jan 1, 2021 Mar 31, 2021 10-K 2022-06-28
Q4 2020 -$224K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $711K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.22M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.